Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Chunmei Yue"'
Autor:
Ran Tao, Chunmei Yue, Zhijie Guo, Wenke Guo, Yao Yao, Xianfa Yang, Zhen Shao, Chao Gao, Jianqing Ding, Lu Shen, Shengdi Chen, Naihe Jing
Publikováno v:
Cell Regeneration, Vol 13, Iss 1, Pp 1-17 (2024)
Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by massive neuronal loss in the brain. Both cortical glutamatergic neurons and basal forebrain cholinergic neurons (BFCNs) in the AD brain are selectively v
Externí odkaz:
https://doaj.org/article/2a0464707d794a51a6cdebcd790a7359
Publikováno v:
Cell Regeneration, Vol 13, Iss 1, Pp 1-10 (2024)
Abstract Continuous immunosuppression has been widely used in xenografts into non-human primate brains. However, how immune responses change after transplantation in host brains under continuous immunosuppressive administration and whether immunosupp
Externí odkaz:
https://doaj.org/article/2cb92029d9a942579fa5ba802a5a9700
Publikováno v:
Cell Regeneration, Vol 11, Iss 1, Pp 1-10 (2022)
Abstract Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder associated with aging. Due to its insidious onset, protracted progression, and unclear pathogenesis, it is considered one of the most obscure and intractable brain disor
Externí odkaz:
https://doaj.org/article/78d467c685344621b7ec85941fdcb489
Autor:
Ting Zhang, Wei Ke, Xuan Zhou, Yun Qian, Su Feng, Ran Wang, Guizhong Cui, Ran Tao, Wenke Guo, Yanhong Duan, Xiaobing Zhang, Xiaohua Cao, Yousheng Shu, Chunmei Yue, Naihe Jing
Publikováno v:
Stem Cell Reports, Vol 13, Iss 6, Pp 1022-1037 (2019)
Summary: Alzheimer's disease (AD) is characterized by memory impairments in its earliest clinical phase. The synaptic loss and dysfunction leading to failures of synaptic networks in AD brain directly cause cognitive deficits of patient. However, it
Externí odkaz:
https://doaj.org/article/761abd4184654fa7846946f0aebe3044
Publikováno v:
iScience, Vol 24, Iss 10, Pp 103207- (2021)
Summary: As an insidious and slowly progressive neurodegenerative disorder, Alzheimer’s disease (AD) uniquely develops in humans but fails in other species. Therefore, it has been challenged to rebuild human AD in animals, including in non-human pr
Externí odkaz:
https://doaj.org/article/f28c4372307a4cf69c757f018123c625
Publikováno v:
STAR Protocols, Vol 2, Iss 1, Pp 100346- (2021)
Summary: Generating induced neural stem/progenitor cells (iNPCs) from somatic cells for medical applications has remained challenging. Here, we describe a reliable protocol to make human iNPCs from a small volume of immobilized adult peripheral blood
Externí odkaz:
https://doaj.org/article/f861a540c60a42deb25a8bac86d761c1
Autor:
Wei Yue, Yuanyuan Li, Ting Zhang, Man Jiang, Yun Qian, Min Zhang, Nengyin Sheng, Su Feng, Ke Tang, Xiang Yu, Yousheng Shu, Chunmei Yue, Naihe Jing
Publikováno v:
Stem Cell Reports, Vol 5, Iss 5, Pp 776-790 (2015)
Degeneration of basal forebrain cholinergic neurons (BFCNs) is associated with cognitive impairments of Alzheimer’s disease (AD), implying that BFCNs hold potentials in exploring stem cell-based replacement therapy for AD. However, studies on deriv
Externí odkaz:
https://doaj.org/article/7ba85f9927094022883229a9fe00ee98
Autor:
Su Feng, Ting Zhang, Wei Ke, Yujie Xiao, Zhong Guo, Chunling Lu, Shuntang Li, Zhongxin Guo, Yuanyuan Liu, Guohe Tan, Yingying Chen, Feng Yue, Yousheng Shu, Chunmei Yue, Naihe Jing
Publikováno v:
Life Medicine. 1:196-206
Human induced neural stem/progenitor cells (iNPCs) are a promising source of cells for stem cell-based therapy. The therapeutic potential of human iNPCs has been extensively tested in animal models, including both mouse and monkey models. However, th
Publikováno v:
Chemical Engineering Journal. 468:143418
Autor:
Naihe Jing, Wenke Guo, Ran Wang, Yanhong Duan, Guizhong Cui, Ran Tao, Xiao-Bing Zhang, Yun Qian, Su Feng, Xiaohua Cao, Wei Ke, Xuan Zhou, Ting Zhang, Chunmei Yue, Yousheng Shu
Publikováno v:
Stem Cell Reports, Vol 13, Iss 6, Pp 1022-1037 (2019)
Stem Cell Reports
Stem Cell Reports
Summary Alzheimer's disease (AD) is characterized by memory impairments in its earliest clinical phase. The synaptic loss and dysfunction leading to failures of synaptic networks in AD brain directly cause cognitive deficits of patient. However, it r